Ohio lawmakers mull breast density legislation

| | Health Imaging | Diagnostic Imaging

Ohio Senate Minority Leader Eric H. Kearney (D-Cincinnati) and President Tom Niehaus (R-New Richmond) have introduced health legislation to provide Ohio women with breast density information when undergoing breast exams. 

Senate Bill 392 will require physicians to inform women of their breast density and possible risks following a mammogram.

If passed, Ohio would be the sixth state to implement a law requiring disclosure to patients following Connecticut, Texas, Virginia, California and New York. Federal legislation has also been introduced in the U.S. House.

For more about breast imaging modalities and breast density, please read “Move Over Mammo,” and “Breast Ultrasound Screening Marches into Practice,” in Health Imaging magazine.

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.